IPT talks to Noor Shaker at X-Chem about the adoption of AI and ML into life sciences and how pre-trained algorithms can aid research
Digital, Dec 14, 2022
IPT talks to Johannes Stanta at Celerion about how improvements in molecular and cellular capabilities are aiding Good Laboratory Practice/Good Clinical Practice (GLP/GCP) standards
Discovery and Development, Dec 14, 2022
IPT talks to Dr Fiona McLaughlin and Neil Bell of Avacta Therapeutics about the need for cohesion when researching and developing a new drug between life science companies, academia, and medical practitioners
Discovery and Development, Dec 14, 2022
What has led to the rising trend for Cell & Gene Therapy (CGT) developers to choose retroviral vectors over other potential vectors, and what are the many drivers behind this selection process?
Discovery and Development, Dec 14, 2022
How are handheld Raman devices and process analysers helping to streamline Quality Control (QC) procedures and enable continuous manufacturing?
Analytics, Dec 14, 2022
IPT recently spoke with Xiaobo Wang at Agilent about what’s been driving demand for flow cytometry and where the technology might be heading
Analytics, Dec 14, 2022
26th January 2023, London UK – Automata, a leading robotics and automation company powering life sciences labs, today announced it is partnering with bit.bio, to automate a key aspect of the manufacturing process of their iPSC (induced pluripotent stem cell)-derived human cell products.
Press Releases, Jan 26, 2023
HAMBURG, GERMANY / ACCESSWIRE / January 26, 2023 / Evotec SE (Frankfurt Stock Exchange:EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ:EVO) announced today that the Company has entered into a strategic collaboration and licence agreement with Janssen Biotech, Inc. ("Janssen"), one of the Janssen Pharmaceutical Companies of Johnson & Johnson.
Press Releases, Jan 26, 2023
SOMERSET, N.J. – January 26, 2023 – Catalent, the leader in enabling the development and supply of better treatments for patients worldwide, today announced the opening of a new commercial-scale plasmid DNA (pDNA) manufacturing facility at its European center of excellence for cell therapies, in Gosselies, Belgium.
Press Releases, Jan 26, 2023
24 January -- CARLSBAD, Calif.--(BUSINESS WIRE)-- As part of a global, multiyear agreement, Thermo Fisher Scientific today announced it is working with AstraZeneca to develop a solid tissue and blood-based companion diagnostic (CDx) test for Tagrisso (osimertinib).
Press Releases, Jan 25, 2023
CARLSBAD, Calif.--(BUSINESS WIRE)-- Thermo Fisher Scientific, the world leader in serving science, today announced the launch of its CE-IVD marked Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit, a Sanger sequencing-based assay that examines positive samples of human immunodeficiency virus (HIV) to identify genetic variants that may resist common antiretroviral therapeutics.
Press Releases, Jan 25, 2023
IPT talks to Noor Shaker at X-Chem about the adoption of AI and ML into life sciences and how pre-trained algorithms can aid research
Digital, Dec 14, 2022
Advancements in AI can help the pharmaceutical industry identify the best sites for their clinical trials through the harnessing of Big Data
Digital, Dec 14, 2022
Blockchain technology is fast becoming a mainstay in pharma companies. What is the draw for these companies to use it, and how can it help improve data collection and protection in the future?
Digital, Dec 14, 2022
How will the mass integration of digital technologies into the pharmaceutical industry benefit the most underserved countries?
Digital, Dec 14, 2022
Concierge services are critical to helping patients navigate technology and other logistics in a decentralised clinical trial. How best can they be implemented?
Digital, Oct 9, 2022
Ensuring pharma products are manufactured in a safe and controlled way is a priority. How can the industry ensure that this happens?
Manufacturing, Dec 14, 2022
Bioprinted products are already starting to demonstrate life-changing potential, but the path to commercialisation is complex, requiring developers to better understand the factors that impact regulatory classification
Manufacturing, Dec 14, 2022
The adaptation of e-cigarettes as drug delivery devices holds great potential for inhalation therapy. So, can we apply the advances made in nicotine delivery to other active substances?
Manufacturing, Oct 9, 2022
In an uncertain environment, using technologies like digital twins and predictive simulation can help forecast the impact of changes across the manufacturing process without affecting current business practices.
Manufacturing, Mar 31, 2022
Michael Avraam at ChargePoint Technology walks IPT through the challenges and obstacles that companies face when looking to build safety, quality, and efficiency into their potent active pharmaceutical ingredient (API) processes
Manufacturing, Mar 31, 2022
Innovative oral therapeutics that meet patients’ needs for ease of use and the desire for more environmentally friendly solutions, have the best chance of success.
Manufacturing, Mar 31, 2022
Smart automation is enabling new ways to monitor and intervene pre-emptively in pharma manufacturing. Find out the views of industry experts, who debated the subject in a roundtable video discussion.
Manufacturing, Mar 31, 2022
The repercussions of events like Brexit and the global pandemic have caused uncertainty and a need to rethink strategy altogether. However, an integrated SaaS solution can provide a holistic view of the business and enhanced control over processes.
Manufacturing, Mar 31, 2022
Pharma has been slow to adopt new technology in its manufacturing plants, partly because it fears change and partly because it often has a mix of legacy equipment. However, embracing greater interoperability through technology can smooth processes and support data integrity.
Manufacturing, Mar 31, 2022
Many elements make up the composition of topical pharmaceutical products, and maintaining the correct rheological characteristics is vital to avoid product quality and even failure.
Manufacturing, Mar 31, 2022
Pharmaceutical companies face plenty of challenges throughout the manufacturing cycle. Automation can be the key to bringing the industry to the forefront of this exciting field
Laboratory Automation, Oct 9, 2022
IPT speaks to Toon Overbeeke of Vitestro about the potential benefits of using robots in clinics to draw blood from patients. With a shortage of clinical staff all over Europe, Toon believes robotics is the way forward regarding individual clinical patient care
Laboratory Automation, Oct 9, 2022
IPT speaks to Mikael Hagstroem, CEO of LabVantage Solutions, about the ongoing potential for laboratories of adopting AI and machine learning (ML)
Laboratory Automation, Oct 9, 2022Smart automation is enabling new ways to monitor and intervene pre-emptively in pharma manufacturing. Find out the views of industry experts, who debated the subject in a roundtable video discussion.
Manufacturing, Mar 31, 2022The repercussions of events like Brexit and the global pandemic have caused uncertainty and a need to rethink strategy altogether. However, an integrated SaaS solution can provide a holistic view of the business and enhanced control over processes.
Manufacturing, Mar 31, 2022
What has led to the rising trend for Cell & Gene Therapy (CGT) developers to choose retroviral vectors over other potential vectors, and what are the many drivers behind this selection process?
Discovery and Development, Dec 14, 2022IPT talks to Dr Fiona McLaughlin and Neil Bell of Avacta Therapeutics about the need for cohesion when researching and developing a new drug between life science companies, academia, and medical practitioners
Discovery and Development, Dec 14, 2022IPT talks to Johannes Stanta at Celerion about how improvements in molecular and cellular capabilities are aiding Good Laboratory Practice/Good Clinical Practice (GLP/GCP) standards
Discovery and Development, Dec 14, 2022
The in vitro-in silico ‘alternative’ bioequivalence pathway for generic inhaled drug products, and how to factor in patient variability to successfully replace your comparative clinical end-point study
Discovery and Development, Dec 14, 2022
From tools and assays, to the need for improved collaboration, the potential answers to this question are numerous. IPT asked representatives from DeciBio, Cybin, and GORE PharmBIO for their opinions
Discovery and Development, Oct 9, 2022IPT recently spoke with Xiaobo Wang at Agilent about what’s been driving demand for flow cytometry and where the technology might be heading
Analytics, Dec 14, 2022How are handheld Raman devices and process analysers helping to streamline Quality Control (QC) procedures and enable continuous manufacturing?
Analytics, Dec 14, 2022
As technology within the analysis sphere continues to evolve, temperature control is becoming increasingly important for drug discovery and research
Analytics, Oct 9, 2022
Innovations in cellular biochemistry are helping to bring better personalised medicine onto the market. How can trapped ion mass spectrometry (TIMS) support this moving forward?
Analytics, Oct 9, 2022
What improvements could High Resolution Ion Mobility (HRIM) bring to separation ability, throughput and reproducibility, and researchers’ understanding of glycoprotein structures?
Analytics, Oct 9, 2022
The ability to visualise in greater detail and with better accuracy can offer laboratories an array of benefits. What new developments are entering the industry, and how can they overcome obstacles to analysis?
Analytics, Oct 9, 2022
Sign up to our newsletters and digital magazines
Browse older editions
IPT provides a platform for cutting-edge ideas, concepts, and developments shaping the future of pharmaceutical R&D.
